Status:
UNKNOWN
Analgesic Efficacy of Ultrasound Guided Erector Spinae Block for Modified Radical Mastectomy
Lead Sponsor:
South Egypt Cancer Institute
Conditions:
Pain, Postoperative
Eligibility:
FEMALE
25-70 years
Phase:
PHASE2
PHASE3
Brief Summary
To compare the analgesic efficacy of dexmedetomidine and magnesium sulphate as adjuvants to levobupivacaine in erector spinae plane block in modified radical mastectomy surgery for acute and chronic p...
Detailed Description
3 groups. Group (C) / (I):20 patient (control group) : Patients will receive 20 ml 0.25% levobupivacaine into the interfascial plane below erector spinae muscle at level of T5. Group (D)/ (II) :20 ...
Eligibility Criteria
Inclusion
- female patient
- American society of anesthesiologists (ASA) I and II physical status
- age from 25 to 70 years old
- scheduled for either left or right modified radical mastectomy (MRM).
Exclusion
- infection of the skin at or near site of needle puncture
- coagulopathy
- drug hypersensitivity or allergy to the studied drugs
- central or peripheral neuropathy
- significant organ dysfunction cardiac dysrrhythmias
- obesity (BMI\>35kg/m2)
- recently use analgesic drugs
Key Trial Info
Start Date :
April 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04732364
Start Date
April 30 2018
End Date
February 28 2021
Last Update
February 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Egypt Cancer Institute
Asyut, Egypt, 171516